Feature Channels: Digestive Disorders

Filters close
Newswise: Gut bacteria found in wild wolves may be key to improving domestic dogs’ health
Released: 4-Oct-2023 7:05 AM EDT
Gut bacteria found in wild wolves may be key to improving domestic dogs’ health
Oregon State University

Gut microbes found in wild wolves may be the key to alleviating a debilitating gastrointestinal condition common to domestic dogs, according to a study led by researchers at Oregon State University – Cascades.

Released: 2-Oct-2023 11:05 AM EDT
Joint IAFNS-USDA Webinar Series Tackles Gut Health, Immune Function
Institute for the Advancement of Food and Nutrition Sciences

Collaborative webinars to focus on key scientific trends and findings related to gut microbiome and nutrition, and the interaction of diet, stress and immune function.

Released: 29-Sep-2023 4:05 PM EDT
الداء البطني مقابل عدم تحمل الغلوتين: خبير مايو كلينك هيلثكير يوضح الفرق
Mayo Clinic

مع ازدياد خيارات الطعام الخالي من الغلوتين، قد يصعُب تقرير ما إذا كان يجب إضافة الغلوتين إلى نظامك الغذائي أم لا. يقول الدكتور سرمد سامي، بكالوريوس الطب والجراحة، طبيب الجهاز الهضمي في مايو كلينك هيلثكير في لندن، أنه لا توجد ضرورة بالنسبة لمعظم الأشخاص لاستبعاد الأطعمة التي تحتوي على الغلوتين بشكل كامل، إذ لا توجد فائدة صحية مثبتة من وراء ذلك. ويشرح الدكتور سامي في هذا التنبيه السبب ويوضح الفرق بين حالتين طبيتين متعلقتين بالغلوتين هما: الداء البطني وعدم تحمل الغلوتين.

Released: 29-Sep-2023 11:05 AM EDT
Doença celíaca versus intolerância ao glúten: especialista da Mayo Clinic Healthcare explica a diferença
Mayo Clinic

Ainda que as opções alimentares livres de glúten estejam aumentando, pode ser difícil tomar a decisão de incluir ou não o glúten na dieta. Para a maioria das pessoas, não existe a necessidade de eliminar completamente os alimentos que contenham glúten e não existem benefícios comprovados a partir da adoção dessa prática, explica o médico cirurgião Dr. Sarmed Sami, gastroenterologista na Mayo Clinic Healthcare em Londres.

Released: 29-Sep-2023 10:40 AM EDT
Celiaquía vs. intolerancia al gluten: un experto de Mayo Clinic Healthcare explica la diferencia
Mayo Clinic

A medida que aumentan las opciones de alimentos sin gluten, puede resultar difícil decidir incluirlo o no en la alimentación. Para la mayoría de las personas, no hay necesidad de eliminar por completo los alimentos que contienen gluten y no se ha demostrado ningún beneficio de hacerlo, afirma el Licenciado en Medicina y Cirugía, Sarmed Sami, gastroenterólogo de Mayo Clinic Healthcare en Londres.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Released: 26-Sep-2023 1:05 PM EDT
Coeliac disease vs gluten intolerance: Mayo Clinic Healthcare expert explains the difference
Mayo Clinic

As gluten-free food options increase, it can be difficult to decide whether to include gluten in your diet or not. For most people, there is no need to completely eliminate foods containing gluten and no proven benefit from doing so, says Sarmed Sami, MBChB, a gastroenterologist at Mayo Clinic Healthcare in London.

Newswise: Combating Crohn’s with comics
Released: 20-Sep-2023 10:00 AM EDT
Combating Crohn’s with comics
Michigan Medicine - University of Michigan

A teenage patient’s unique way of detailing his experience with Crohn’s disease

Released: 19-Sep-2023 9:25 AM EDT
Inflammatory Bowel Disease Linked to Atopic Dermatitis, Penn Medicine Research Finds
Perelman School of Medicine at the University of Pennsylvania

Adults with atopic dermatitis (AD) have a 34 percent increased risk of developing new-onset inflammatory bowel disease (IBD) compared with individuals who do not have the skin condition, and children have a 44 percent increased risk, according to a new study from the Perelman School of Medicine at the University of Pennsylvania.

Not for public release

This news release is embargoed until 11-Sep-2023 5:00 PM EDT Released to reporters: 5-Sep-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 11-Sep-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-Sep-2023 11:05 AM EDT
ينشر باحثو مايو كلينك النتائج الرئيسية حول بروتينات الخلايا لتحديد فعالية العلاج المناعي لسرطان القولون
Mayo Clinic

روشستر، مينيسوتا — مركز مايو كلينك الشامل لعلاج السرطان حدد الباحثون النتائج الرئيسية التي يمكن أن تساعد الأطباء في التنبؤ بما إذا كان المريض مصابًا بسرطان المستقيم والقولون المتقدم سيستفيد من العلاج المناعي. نُشرت الدراسة في مجلة أبحاث السرطان السريرية كلينيكال كانسر ريسيرش Clinical Cancer Research وتُبرز إمكانية استخدام التحليل المكاني لبروتينات معينة كأداة تنبؤية لاختيار المرشحين المناسبين للعلاج المناعي بحصار PD-1 في سرطان القولون والمستقيم، ممّا يؤدي في النهاية إلى تحسين نتائج العلاج وتقليل الحاجة إلى العلاجات غير الضرورية.

Released: 7-Sep-2023 11:05 AM EDT
Investigadores de Mayo Clinic publican hallazgos clave sobre proteínas celulares para determinar la eficacia de la inmunoterapia contra el cáncer de colon
Mayo Clinic

Los investigadores del Centro Oncológico Integral de Mayo Clinic han identificado hallazgos clave que pueden ayudar a los médicos a predecir si un paciente con cáncer colorrectal avanzado se beneficiará de la inmunoterapia.

Released: 7-Sep-2023 11:05 AM EDT
Pesquisadores da Mayo Clinic publicam as principais descobertas sobre proteínas celulares para determinar a eficácia da imunoterapia para câncer de cólon
Mayo Clinic

Os pesquisadores do Centro de Câncer da Mayo Clinic identificaram as principais descobertas que podem ajudar médicos a prever se um paciente com câncer colorretal avançado será beneficiado com a imunoterapia.

Newswise: Liver-Associated and Age-Related Studies Included in the September Issue of AJG
Released: 7-Sep-2023 10:00 AM EDT
Liver-Associated and Age-Related Studies Included in the September Issue of AJG
American College of Gastroenterology (ACG)

Research updates in gastroenterology and hepatology from the September issue of The American Journal of Gastroenterology, the flagship journal of the American College of Gastroenterology.

Released: 6-Sep-2023 10:25 AM EDT
Third NIH Grant Moves Novel Anti-Diarrheal Vaccine Forward
College of Veterinary Medicine, University of Illinois Urbana-Champaign

Dr. Weiping Zhang, professor in the Department of Pathobiology, was recently awarded a five-year, $5.6 million R01 grant from the National Institutes of Health (NIH) to optimize a promising vaccine against enterotoxigenic Escherichia coli (ETEC).

Newswise: Intestinal bacteria release molecular ‘brake’ on weight gain
Released: 31-Aug-2023 12:05 PM EDT
Intestinal bacteria release molecular ‘brake’ on weight gain
UT Southwestern Medical Center

Bacteria that live in the intestines inhibit a molecule that limits the amount of fat absorbed, increasing weight gain in mice fed a high-sugar, high-fat diet, researchers from UT Southwestern Medical Center report. The findings, published in Science, could eventually lead to new ways to combat obesity, diabetes, and malnutrition – health problems that plague hundreds of millions worldwide.

Released: 31-Aug-2023 9:55 AM EDT
Mayo Clinic researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer
Mayo Clinic

Mayo Clinic Comprehensive Cancer Center researchers have identified key findings that can assist clinicians in predicting whether a patient with advanced colorectal cancer will benefit from immunotherapy.

Not for public release

This news release is embargoed until 28-Aug-2023 5:00 PM EDT Released to reporters: 22-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 28-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Aug-2023 11:30 AM EDT
Altis Biosystems Launches RepliGut® Planar InflammaScreen Services to Accelerate Drug Discovery for Inflammatory Bowel Diseases
Altis Biosystems

Altis Biosystems, a leader in developing innovative, in vitro cell-based model systems for drug discovery, announces the launch of RepliGut® Planar InflammaScreen™ Services.

Newswise: Mutations in blood stem cells can exacerbate colon cancer
21-Aug-2023 9:45 AM EDT
Mutations in blood stem cells can exacerbate colon cancer
The Rockefeller University Press

Researchers at the University of Florida College of Medicine have discovered how common age-related changes in the blood system can make certain colon cancers grow faster.



close
2.16415